Category: Approval/Launch Region: Asia · India Company: Sun Pharma Advanced Research Co Ltd

Sun Pharma Awaiting Regulator Nod To Launch Covid-19 Drug In India

Sun Pharma Awaiting Regulator Nod To Launch Covid-19 Drug In India
Molnupiravir Is The First Oral Antiviral Approved By The Uk Medicines And HealthcareProducts Regulatory Agency (Mhra) For The Treatment Of Mild-To-Moderate Covid-19 In Adults, And Is Under Review By The Us Food And Drug AdministrationSun Pharma: Drug Cos Including, Sun Pharma, Awaiting Regulator Nod To Launch Covid-19 Drug In India, Health News, Et Health

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!